D69.5
Secondary thrombocytopenia
Clinical Classification Guidelines
Excludes Type 1
- heparin induced thrombocytopenia (HIT) (D75.82-)
- transient thrombocytopenia of newborn (P61.0)
Medical Intelligence & Overview
Secondary thrombocytopenia is a condition characterized by a decreased number of platelets in the blood that results from another underlying health issue. Platelets are crucial components of blood involved in clotting, and their reduced levels can affect the body's ability to stop bleeding. This condition is distinguished from primary thrombocytopenia, where the low platelet count occurs without an apparent cause. Recognizing secondary thrombocytopenia involves identifying and treating the underlying disease that leads to decreased platelet production or increased destruction.
Causes & Symptoms
Clinical Causes: Infections such as HIV, hepatitis C, or other viral illnesses Use of certain medications including antibiotics, chemotherapy, and anticonvulsants Autoimmune diseases, like lupus or immune thrombocytopenic purpura Bone marrow disorders such as leukemia or aplastic anemia Splenomegaly (enlarged spleen) which sequesters platelets Alcohol abuse leading to impaired platelet production Nutritional deficiencies, especially vitamin B12 or folate deficiency
Key Symptoms: Unusual or excessive bruising Petechiae—small red or purple spots on the skin Prolonged bleeding from cuts Bleeding gums or nosebleeds Heavy menstrual periods Fatigue or weakness in some cases Signs of underlying illness, such as fever or weight loss
Diagnostic & Treatment
Diagnosis Path: Diagnosing secondary thrombocytopenia involves blood tests that measure platelet levels, such as a complete blood count (CBC). To understand the underlying cause, additional tests may include bone marrow biopsies, autoimmune panels, or screening for infections. Medical history and physical examination help identify signs of infections, autoimmune disorders, or other illnesses that could be responsible.
Treatment Protocols: Management of secondary thrombocytopenia focuses on addressing the root cause of the condition. This may include stopping or switching medication, treating infections, controlling autoimmune activity, or managing bone marrow disorders. In some cases, supportive therapies like platelet transfusions or corticosteroids might be used to temporarily increase platelet levels. Long-term treatment plans depend on the specific underlying condition identified.
Clinical Advice & FAQs
Billing Guidance
Is D69.5 a billable ICD-10 code?
Yes, D69.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D69.5?
Clinical documentation must specify the nature of Secondary thrombocytopenia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference